Tenet Healthcare Corp. (NYSE: THC) on Friday, soared 1.34% from the previous trading day, before settling in for the closing price of $161.71. Within the past 52 weeks, THC’s price has moved between $51.04 and $171.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 2.48%. The company achieved an average annual earnings per share of 51.63%. With a float of $93.44 million, this company’s outstanding shares have now reached $99.95 million.
Considering the fact that the conglomerate employs 106500 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 30.3%, operating margin of 12.99%, and the pretax margin is 21.68%.
Tenet Healthcare Corp. (THC) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Care Facilities industry stocks is more important than anything else. The insider ownership of Tenet Healthcare Corp. is 2.49%, while institutional ownership is 95.92%. The most recent insider transaction that took place on Sep 05 ’24, was worth 1,879,734. In this transaction Principal Accounting Officer of this company sold 11,599 shares at a rate of $162.06, taking the stock ownership to the 6,324 shares. Before that another transaction happened on Aug 27 ’24, when Company’s Director sold 2,000 for $163.67, making the entire transaction worth $327,332. This insider now owns 14,227 shares in total.
Tenet Healthcare Corp. (THC) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 51.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.95% during the next five years compared to 40.40% growth over the previous five years of trading.
Tenet Healthcare Corp. (NYSE: THC) Trading Performance Indicators
Tenet Healthcare Corp. (THC) is currently performing well based on its current performance indicators. A quick ratio of 1.38 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.75. Likewise, its price to free cash flow for the trailing twelve months is 8.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 27.33, a number that is poised to hit 2.35 in the next quarter and is forecasted to reach 11.31 in one year’s time.
Technical Analysis of Tenet Healthcare Corp. (THC)
Compared to the last year’s volume of 1.19 million, its volume of 0.88 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 85.19%. Additionally, its Average True Range was 4.91.
During the past 100 days, Tenet Healthcare Corp.’s (THC) raw stochastic average was set at 82.84%, which indicates a significant decrease from 88.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.22% in the past 14 days, which was higher than the 29.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $159.63, while its 200-day Moving Average is $124.02. Nevertheless, the first resistance level for the watch stands at $166.04 in the near term. At $168.20, the stock is likely to face the second major resistance level. The third major resistance level sits at $171.65. If the price goes on to break the first support level at $160.43, it is likely to go to the next support level at $156.98. Now, if the price goes above the second support level, the third support stands at $154.82.
Tenet Healthcare Corp. (NYSE: THC) Key Stats
Market capitalization of the company is 15.70 billion based on 97,683K outstanding shares. Right now, sales total 20,548 M and income totals 611,000 K. The company made 5,103 M in profit during its latest quarter, and 259,000 K in sales during its previous quarter.
